Palivizumab Biosimilar, RSV mAb
Item Information
Catalog #
Size
Price
Description
Palivizumab is a humanized IgG1-kappa monoclonal antibody specific for the F protein of respiratory syncytial virus (RSV). Palivizumab blocks F protein-mediated viral entry into cells, inhibiting RSV infection.
Product Overview
Isotype
IgG1 kappa
Source
Produced in the CHO stable cell line.
Formulation
0.2-uM filtered solution, pH 6.0, no stabilizers or preservatives
Purity
>95% by SDS-PAGE under reducing conditions and HPLC
Endotoxin
<1 EU/mg (LAL method)
Specificity/Sensitivity
Binds to RSV protein F.
Storage
4°C if used within 1 month, -20°C otherwise
Shipping Information
Shipped with an ice pack.
Application
ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and assays for studying the biological pathways affected by Palivizumab.
For Research Use Only. Not for use in diagnostic procedures.